Is the effect of cognitive behaviour therapy for chronic fatigue syndrome (ME/CFS) moderated by the presence of comorbid depressive symptoms? A meta-analysis of three treatment delivery formats. — CFSMEATLAS
Is the effect of cognitive behaviour therapy for chronic fatigue syndrome (ME/CFS) moderated by the presence of comorbid depressive symptoms? A meta-analysis of three treatment delivery formats.
Kuut, T A, Buffart, L M, Braamse, A M J et al. · Journal of psychosomatic research · 2024 · DOI
Quick Summary
This study looked at whether cognitive behaviour therapy (CBT) works differently for ME/CFS patients depending on whether they also have depression. The researchers combined data from six clinical trials with over 1,000 patients and found that for internet-based CBT, patients with depression improved less than those without depression. However, for face-to-face CBT (whether one-on-one or in groups), depression didn't seem to affect how much patients improved.
Why It Matters
This research directly addresses an important clinical gap: understanding which ME/CFS patients benefit most from different CBT formats. For patients with both ME/CFS and depression—a common combination—the findings suggest choosing face-to-face CBT may lead to better outcomes, potentially improving treatment selection and patient outcomes.
Observed Findings
In internet-based CBT, patients with comorbid depressive symptoms showed significantly less reduction in fatigue severity compared to those without depressive symptoms.
Patients with depressive symptoms in internet-based CBT remained more often severely fatigued post-treatment than non-depressed patients.
In individual face-to-face CBT, depressive symptoms did not significantly moderate treatment effects on fatigue severity.
In group face-to-face CBT, depressive symptoms did not significantly moderate treatment effects on fatigue severity.
No moderation by depressive symptoms was found for functional impairment or physical functioning outcomes across any delivery format.
Inferred Conclusions
Face-to-face CBT (individual or group) is currently the preferred delivery format for ME/CFS patients with comorbid depressive symptoms.
Internet-based CBT requires further development to be equally effective for ME/CFS patients experiencing depression.
The therapeutic alliance and direct contact in face-to-face settings may buffer against the negative impact of depressive symptoms on treatment outcomes.
Remaining Questions
What specific mechanisms explain why depression moderates internet-based CBT efficacy but not face-to-face CBT efficacy?
What This Study Does Not Prove
This study does not prove that depression causes reduced CBT effectiveness; rather, it shows an association in internet-based treatment. The findings also do not address whether treating depression first might improve subsequent CBT outcomes, nor do they establish mechanisms explaining why depression moderates internet-based but not face-to-face CBT.